
Health
11 Aug 2020
Researchers show mathematically how to best reopen your business after lockdown
How should you reopen your business after Covid19 lockdown? Frontiers in Applied Mathematics and Statistics
Health
11 Aug 2020
How should you reopen your business after Covid19 lockdown? Frontiers in Applied Mathematics and Statistics
Health
04 Aug 2020
Penis microbiota important for development of bacterial vaginosis: Frontiers in Cellular and Infection Microbiology
Health
27 Jul 2020
By Carolyn E. Unck | KAUST Discovery A likeness between genes of the SARS and COVID-19 viruses could inform research into potential treatments Understanding any similarities between SARS and COVID-19 inflammation could help in a clinical setting. A protein in the viruses causing COVID-19 and SARS is almost identical. Researchers propose testing if targeting COVID-19 with FDA-approved drugs, already tested in mice infected with SARS, could improve the outcomes for COVID-19 patients experiencing severe respiratory symptoms. The finding was a collaborative effort from teams at KAUST following a comparison of Betacoronavirus genomes. “We have long-standing expertise in analyzing genomic data at KAUST’s Computational Bioscience Research Center,” says molecular biologist, Takashi Gojobori. Gojobori, Carlos M. Duarte and a team of scientists compared the genomes of 24 Betacoronaviruses, including four SARS-CoV-2 viruses, which causes COVID-19. Two of the four were sequenced in the United States, while the other two were sequenced in China. “SARS-CoV-2 appears to have recently evolved from other related Betacoronaviruses, such as the ones causing SARS and Middle East respiratory syndrome (MERS),” explains Intikhab Alam, first author of the study. “We wanted to understand the genetic make up of SARS-CoV-2. Seeing what has changed might help find ways to detect the virus and understand its […]
Health
24 Jun 2020
Reducing high pulse pressure could be a promising new prevention for dementia: Frontiers in Neuroscience
Health
10 Jun 2020
Model shows that ending lockdown in two steps is optimal, while suddenly releasing everyone is a high-risk strategy: Frontiers in Public Health
Health
05 Jun 2020
Lockdown succeeded in reducing transmission, but existing cases and lack of herd immunity means the risk of a second wave is high: Frontiers in Medicine
Health
29 May 2020
Study outlines key factors underlying COVID-19 progression and proposes a range of drug treatments: Frontiers in Immunology
Health
25 May 2020
Mortality risk factors include old age, underlying health conditions, and bacterial and respiratory co-infections: Frontiers in Medicine
Health
15 May 2020
IFN-α2b was shown to improve virus clearance and decrease levels of inflammatory markers: Frontiers in Immunology
Health
13 May 2020
New study explains the mechanisms, symptoms, and diagnosis of the new coronavirus: Frontiers in Public Health
Health
12 May 2020
Gastrointestinal symptoms, coupled with a fever or history of exposure to COVID-19, could indicate coronavirus infection in children: Frontiers in Pediatrics
Health
08 May 2020
Test can identify an infected person in 15 minutes at point-of-care sites that lack facilities or time for sophisticated testing: Frontiers in Medicine
Health
06 May 2020
Preventive measures in Hunan limited the spread of the novel coronavirus compared to the epidemic in Italy: Frontiers in Medicine
Health
01 May 2020
Inflammatory response can cause T cells to become depleted, leaving patients prone to secondary infection: Frontiers in Immunology
Health
30 Apr 2020
Patients can be at risk of cardiovascular impairment and should be given proven treatments to aid survival and recovery: Frontiers in Cardiovascular Medicine
Get the latest research updates, subscribe to our newsletter